Overexpression of β-arrestin 2 in peripheral blood mononuclear cells of patients with cryptococcal meningitis

Journal of Interferon and Cytokine Research

Volumn 30, Issue 3, 2010, Pages 155-161

  Xia, Rong ^a   Hu, Zhide ^b   Sun, Yi ^b   Chen, Sunxiao ^c   Gu, Mingli ^b   Zhou, Ye ^b   Han, Zhijun ^b   Zhong, Renqian ^b   Deng, Anmei ^b   Wen, Hai ^c  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA ARRESTIN 2; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ARRESTINS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MENINGITIS, CRYPTOCOCCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77949820605     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0017     Document Type: Article

References (25)

1. Barki-Harrington L, Rockman HA. 2008. Beta-arrestins: multifunctional cellular mediators. Physiology 23:17-22
2. Biondo C, Midiri A, Gambuzza M, Gerace E, Falduto M, Galbo R, Bellantoni A, Beninati C, Teti G, Leanderson T, Mancuso G. 2008. IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J Immunol 181:566-573
3. Guerrero A, Fries BC. 2008. Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect Immun 76:4322-4331
4. Jarvis JN, Harrison TS. 2007. HIV-associated cryptococcal meningitis. AIDS 21:2119-2129
5. Kawamata Y, Imamura T, Babendure JL, Lu JC, Yoshizaki T, Olefsky JM. 2007. Tumor necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signaling complex. J Biol Chem 282:28549-28556
6. Lewis JS, II, Graybill JR. 2008. Fungicidal versus Fungistatic: what's in a word? Expert Opin Pharmacother 9:927-935
7. Lu H, Zhou Y, Yin Y, Pan X, Weng X. 2005. Cryptococcal antigen test revisited: signifi cance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 43:2989-2990
8. Lynch MJ, Baillie GS, Houslay MD. 2007. cAMP-specifi c phosphodiesterase- 4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling. Biochem Soc Trans 35:938-941
9. Ma L, Pei G. 2007. Beta-arrestin signaling and regulation of transcription. J Cell Sci 120:213-218
10. Netea MG, Brouwer AE, Hoogendoorn EH, Van der Meer JW, Koolen M, Verweij PE, Kullberg BJ. 2004. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferongamma therapy. Clin Infect Dis 39:e83-e87
11. Nielsen K, De Obaldia AL, Heitman J. 2007. Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization. Eukaryot Cell 6:949-959
12. Pasqualotto AC, Denning DW. 2008. New and emerging treatments for fungal infections. J Antimicrob Chemother 61(Suppl 1):i19-i30
13. Pietrella D, Lupo P, Bistoni F, Vecchiarelli A. 2004. An early imbalance of interleukin 12 infl uences the adjuvant effect of mannoproteins of Cryptococcus neoformans. Cell Microbiol 6:883-891
14. Pukkila-Worley R, Mylonakis E. 2008. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 9:551-560
15. Scheinecker C, Redlich K, Smolen JS. 2008. Cytokines as therapeutic targets: advances and limitations. Immunity 28:440-444
16. Schop J. 2007. Protective immunity against Cryptococcus neoformans infection. Mcgill J Med 10:35-43
17. Segal BH, Steinbach WJ. 2007. Combination antifungals: an update. Expert Rev Anti Infect Ther 5:883-892
18. Siddiqui AA, Brouwer AE, Wuthiekanun V, Jaffar S, Shattock R, Irving D, Sheldon J, Chierakul W, Peacock S, Day N, White NJ, Harrison TS. 2005. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol 174:1746-1750
19. Siehler S. 2008. Cell-based assays in GPCR drug discovery. Biotechnol J 3:471-483
20. Singh N, Husain S, Limaye AP, Pursell K, Klintmalm GB, Pruett TL, Somani J, Stosor V, del Busto R, Wagener MM, Steele C. 2006. Systemic and cerebrospinal fl uid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. Transpl Immunol 16:69-72
21. Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P. 2008. Immunological profi les of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 9:307-316
22. Vecchiarelli A. 2007. Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity. Crit Rev Immunol 27:547-557
23. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. 2006. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptorinterleukin 1 receptor signaling. Nat Immunol 7:139-147
24. Wu H, Wei W, Song L, Zhang L, Chen Y, Hu X. 2007. Paeonifl orin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-adrenergic receptor desensitization in rats with adjuvant arthritis. Int Immunopharmacol 7:662-673
25. Yu MC, Su LL, Zou L, Liu Y, Wu N, Kong L, Zhuang ZH, Sun L, Liu HP, Hu JH, Li D, Strominger JL, Zang JW, Pei G, Ge BX. 2008. An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol 9:898-907